During a 1-year epidemiological investigation of the mucocutaneous leishmaniasis in the endemic area round the Rio Pachitea (Peruvian virgin forest, catchment area of the upper Rio Ucayali), we diagnosed 120 cases of leishmaniasis tegumentaria sudamericana (Espundia). Of these cases 27 were treated at the local tropical medicine clinic at Puerto Inca: 6 of them received stibophen, and 21 of them stibophen, and 21 of them amphotericin B. The treatment of leishmaniasis tegumentaria sudamericana with amphotericin B is discussed in detail. The use of stibophen is confined to fresh skin ulcers, while amphotericin B is the only drug known to date that holds out hope of success in all mucocutaneous and chronic forms of the disease.

Keywords:
Leishmaniasis tegumentaria in Peru, Treatment with amphotericin B, Treatment with stibophen
This content is only available via PDF.
© 1974 S. Karger AG, Basel
1974
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.